Exam 2 - Urinary Incontinence

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/40

encourage image

There's no tags or description

Looks like no tags are added yet.

41 Terms

1
New cards

Learning Objectives

  • Describe the normal micturition cycle

  • List the physiologic factors responsible for the maintenance of urinary continence

  • Explain the pathophysiologic basis for the main types of urinary continence

  • Compare and contrast the clinical presentations of the main types of urinary continence

  • Identify drugs that can precipitate new-onset or aggravate existing urinary incontinence

  • Describe the components of the physical examination of a patient undergoing evaluation for urinary incontinence

  • Discuss diagnostic tests that can assist in the evaluation of patient with urinary incontinence

  • Compare and contrast nonpharmacologic treatments of the main types of urinary incontinence

  • List the factors guiding selection of a specific drug for urinary incontinence for an individual patient

  • Select an appropriate drug for urinary incontinence based on specific data

  • List factors affecting adherence for a patient receiving drug therapy for urinary incontinence

  • Formulate a monitoring plan for a patient on drug therapy for urinary incontinence based on a patient-specific information and the prescribed regimen

  • Formulate appropriate counseling information to be provided to a patient receiving drug therapy for urinary incontinence, given patient-specific information and the prescribing regimen


2
New cards

Which receptors does the bladder have?

Bladder has M1, M2, and M3 receptors

  • Made up of stretchable smooth muscle (detrusor)

  • Richly innervated by parasympathetic fibers; specifically muscarinic

  • Detrusor muscle → controls contraction and relaxation of bladder


Bladder has muscarinic, beta-adrenergic, and alpha-adrenergic receptors

3
New cards

What is the internal sphincter?

Internal sphincter - Not a true sphincter but a continuation of smooth muscle of the bladder

  • Sympathetic alpha-adrenergic fibers

  • Facilitates smooth muscle sphincter contraction and relaxation


4
New cards

What is the external sphincter?

Skeletal muscle that is under voluntary control

  • Allows you to control when/when not to pee


5
New cards

Stimulation of which receptors of the detrusor muscle allows for smooth muscle relaxation of the bladder?

Beta-3

6
New cards

What is micturiton and what are the steps that lead to peeing?

Micturition → the action of urinating

1) The bladder fills

  • Detrusor muscle relaxes

  • Urethral sphincter contracts

  • Pelvic floor contracts

2) First sensation to void

  • Bladder half full, urination voluntarily inhibited until appropriate time

3) Normal desire to void

4) Micturition

  • Detrusor muscle contracts

  • Pelvic floor relaxes


7
New cards

What is the defined as overactive bladder?

Overactive Bladder (OAB)

  • A medical condition involving:

    • Sudden, strong urges to urinate

    • Urinary frequency (> 8 times/day)

    • Nocturia (> 2 times/night)

    • Incomplete bladder emptying

    • Hallmark symptom is urgency to urinate

  • OAB is a distinct diagnosis involving abnormal nerve signaling or involuntary detrusor contractions


8
New cards

What is defined as urinary incontinence?

Urinary Incontinence (UI)

  • Involuntary leakage of urine (leakage is primary feature)

  • Characterized by:

    • Weakened pelvic floor muscles

    • Physical stress (coughing, laughing)

    • Incomplete bladder emptying

    • Functional limitation

  • UI is a symptom/outcome as opposed to OAB being a diagnosis


9
New cards

Compare overactive bladder and urinary incontinence


10
New cards

What are the 5 different types of urinary incontinence?

Stress, Urge, Overflow, Functional, and Mixed

11
New cards

What is stress urinary incontinence and what is it caused by?

Involuntary loss of urine (usually in small amounts) with increases in intra-abdominal pressure (which can be caused by coughing, laughing, exercise)

  • Causes:

    • Weakness of the pelvic floor musculature and weakness of internal/external urethral sphincter

    • Sometimes referred to as “urethral underactivity”

    • Common in younger females after childbirth


12
New cards

What is urge urinary incontinence and what is it caused by?

Large volume urinary leakage because of an inability to delay voiding after sensation of bladder fullness is perceived

  • Causes:

    • Idiopathic or unknown

    • Detrusor instability

    • CNS disorders, e.g. strokes

    • Genitourinary conditions


13
New cards

What is overflow urinary incontinence and what is it caused by?

Leakage of urine (usually in small amounts) resulting from mechanical forces on an overly distended bladder or from other effects of urinary retention on bladder and sphincter function

  • Causes:

    • Anatomic obstruction → Benign Prostatic Hypertrophy

    • Neurologic acontractility

      • Spinal cord injury

      • Diabetes

    • Medications

      • Meds with anticholinergic properties

      • TCA’s

      • Antihistamines

      • Antipsychotics

      • Opiates


14
New cards

What is functional urinary incontinence and what is it caused by?

Urinary leakage associated with the inability to reach the toilet because of impairment of cognitive and/or physical functioning, psychological unwillingness, or environmental barriers

  • Causes:

    • Physical disability

    • Dementia

    • Multiple sclerosis

    • Medications that cause drowsiness or affect balance


15
New cards

What are nonpharm therapies for urinary incontinence?

  • Pelvic muscle exercises (Kegel exercises)

  • Minimizing fluid intake ≤ 2 liters/day

  • Avoidance of caffeinated beve rages, smoking, and alcohol

  • Minimizing evening fluid intake to reduce likelihood for nocturnal incontinence

  • Weight loss if overweight (40% effective with SUI)

  • Take diuretics early in the day to avoid nocturia


16
New cards

What is bladder training?

Bladder training - helps to increase how long a patient can wait before having to urinate

1. Keep a voiding diary for 24 hours

2. Track the shortest time before needing to urinate again

3. Using the shortest time, make a schedule to go the toilet at this interval all day long

4. Go at these times whether feeling the need or not

5. Upon reaching a point in which there is no leaking for a full day, increase schedule by 15 minutes

6. Do this until you are comfortable every 3-4 hours

17
New cards

What are clinical pearls of pharmacologic therapy of UI?

  • Behavioral therapy is first line for all types of Urinary Incontinence, except in cases of urinary obstruction (BPH and Obstructive uropathies)

  • For best results, pharmacological therapy should be continued with behavioral therapy after behavioral therapy alone has failed

  • Drug therapy for Urinary Incontinence is primarily limited to the treatment of Urge Incontinence

  • Use the lowest doses for the shortest time possible


18
New cards

Drug therapy for urinary incontinence is primarily limited to?

Urge incontinence

19
New cards

Which muscarinic antagonists are used in urinary incontinence?

  • Oxybutynin

    • IR (Ditropan)

    • ER (Ditropan XL)

    • Transdermal patch (Oxytrol)

    • Gel (Gelnique)

  • Tolterodine

    • IR (Detrol) → Max dose 2mg BID

    • ER (Detrol LA) → Max dose 4mg once daily

  • Trospium chloride

    • IR (Sanctura) → Max: 20mg BID

    • ER (Sanctura) → Max: 60mg BID

  • Darifenacin

  • Solifenacin

  • Fesoterodine


20
New cards

What are side effects seen with muscarinic receptor antagonists? (oxybutynin, tolterodine, solifenacin)

  • Anticholinergic AEs: dry mouth, constipation, headache, dyspepsia, dry eyes, blurred vision, cognitive impairment, tachycardia, sedation, orthostatic hypotension

  • In general: ER, LA, XL and topical products are associated with fewer adverse effects, particularly dry mouth!


21
New cards

What is the MOA of Beta-3 Adrenergic Agonists?

  • Selective Beta-3 stimulation of the detrusor muscle leading to smooth muscle relaxation and increased bladder capacity

  • Less dominant pathway, but efficacy demonstrated

  • Similar moderate efficacy as antimuscarinics


22
New cards

Compare the efficacy of Tolterodine and Oxybutynin

Tolteridine has less anticholinergic adverse effects than oxybutynin

  • Reasonable 1st line choice in patients prone to anticholinergic effects


23
New cards

What is the role of urinary incontinence agents in patients with dementia?

The risk of using these agents generally outweigh the benefits

  • Patients with dementia are oftentimes prescribed cholinesterase inhibitors which causes/worsens urge incontinence


24
New cards

Which beta-3 agonists are used for UI?

  • Mirabegron ER (Mybetriq):

    • Starting dose: 25mg po once daily

    • Maximum dose: 50mg po once daily

  • Vibegron (Gemtesa):

    • Starting dose: 75mg po once daily

    • Maximum dose: 75mg po once daily


25
New cards

What are side effects associated with beta3-adrenergic antagonists?

Hypertension, nasopharyngitis, urinary tract infections, headaches

26
New cards

Which UI agents are metabolized by CYP3A4 pathway?

Oxybutynin, Tolterodine, Solifenacin, Darifenacin, and Fesoteridine

27
New cards

Drug interactions: Dose of urinary incontinence medications should be reduced by 50% when administered concomitantly with which medications?

Fluoxetine

Sertraline

Fluvoxamine

Erythromycin, clarithromycin

Itraconazole, ketoconazole

Grapefruit juice

28
New cards

Which UI agent has DIs with antacids?

Tolteridine LA

  • Coadministration with antacids → 150% elevation in peak levels

  • Separate time of administration by 4 hours


29
New cards

Which OTC product can be used to treat UI?

Oxytrol for Women

  • Transdermal oxybutynin patch delivers a steady dose of 3.9 mg/ day over four days

  • Apply to abdomen, hip, or buttock

  • Patch is thin, clear and flexible

  • Helps reduce:

    • Urinary urgency

    • Frequency

    • Incontinence

    • Night-time urination

  • May be combined with non-pharm for best results


30
New cards

What is the role of botox in treatment of UI?

May be considered after other treatments (behavioral, medications) fail

  • FDA-approved for treatment of urge urinary incontinence


Injected into the detrusor muscle of the bladder wall resulting in:

1) bladder relaxation

2) increased storage capacity, and

3) reduced episodes of urinary incontinence

31
New cards

What is the duration of tx of botox and risks of using?

  • Symptom improvement typically seen within 2-3 weeks; some feel relief within 48 hours

  • Effects last 6-12 months, with repeat injections as needed

  • Risks include: urinary retention, UTIs, cramping and discomfort


32
New cards

What is the role of electrical therapies in UI?

  • Considered after behavioral and pharmacologic therapies

  • Bladder stimulators

    • FDA-approved for treatment of stress urinary incontinence

    • Uses low-grade electrical current to stimulate weak or inactive pelvic muscles to contract

    • Regular sessions can augment a patient’s pelvic muscle exercise regime


33
New cards

What are the two types of electrical therapies?

1) Sacral Neuromodulation

2) Percutaneous Tibial Nerve Stimulation

34
New cards

Sacral neuromodulation

  • A small device is implanted under the skin of the buttock

  • Sends electrical signals to nerves that control bladder and bowel function

  • Includes trial phase lasting 4-14 days to confirm benefit before implantation

  • Options

    • Rechargeable

    • Recharge-free with battery life up to 15-20 years

  • Devices

    • Medtronic InterStim

    • Axonics SNM


35
New cards

Peripheral Tibial Nerve Stimulation (PTNS)

  • PTNS therapy typically involves two phases:

    • Induction phase: 12 weekly sessions, with most patients noticing improvement by the 6th session

    • Maintenance phase: After successful induction, sessions are spaced every 3-4 weeks or as needed to sustain symptom relief

    • During 30-minute treatment session:

      • Small slim needle electrode inserted near the ankle

      • Needle electrode connected to battery-powered stimulator

      • Mild impulses from the stimulator travel through needle electrode, along the posterior tibial nerve of the leg, to nerves in the pelvis that control bladder and pelvic floor function


36
New cards

What procedure can be performed for treatment of UI?

Sling procedure

  • Used for treatment of stress urinary incontinence

    • Places a thin strip of synthetic mesh under the urethra like a hammock

    • Provides support for the urethra and bladder neck so they stay closed during coughing, sneezing, lifting, or exercise

  • Types of sling procedures

    • Mid-urethral sling (most common)

    • Traditional Pubovaginal Sling

    • Male Sling Procedure

  • Risks: Bleeding, infection, blood clots


37
New cards

What is 1st line therapy for stress urinary incontinence?

Behavioral

38
New cards

Which agents should be AVOIDED in stress urinary incontinence?

1) Oral conjugated estrogens

  • Increase urinary incontinence rates

  • Avoid use

2) Oral alpha agonists - No longer recommended due to increased BP and stroke risk

  • Ephedrine, pseudoephedrine, phenylephrine

3) Alpha blockers

  • Doxazosin, Terazosin


39
New cards

What is the most common cause of OVERFLOW incontinence in men?

Benign prostatic hyperplasia

40
New cards

Which medications should be avoided in patients with overflow urinary incontinence?

Avoid anticholinergic medications which can lead to acute urinary retention → hydronephrosis → Post-renal failure

41
New cards

How do we differentiate urge vs overflow incontinence?

Post-void residuals (PVR) allow for differentiation:

  • After urination, a straight urinary catether is placed to empty any residual urine from the bladder → The volume of urine obtained = post-void residual (PVR)

    • PVR < 50 mL → Probably not overflow incontinence

    • PVR > 200 mL → May be overflow incontinence


  • Overflow incontinence is typically accompanied by hesitance when attempting to urinate